Crohn's and ulcerative colitis — chronic gut inflammation where anti-inflammatory peptides draw interest.
IBD (Crohn's disease and ulcerative colitis) involves genuine, chronic intestinal inflammation. KPV is the most relevant peptide here — it's an alpha-MSH fragment with documented anti-inflammatory action in colitis models — with BPC-157 for barrier support.
This is serious, diagnosable disease requiring gastroenterology care and proven therapies. The peptide interest is preclinical; nothing here replaces medical management, and uncontrolled IBD has real complications.
Ranked by editorial relevance — a measure of how central each compound is to the conversation, not a claim of effectiveness.